PMC:7408073 / 6251-6522 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"249","span":{"begin":165,"end":170},"obj":"Gene"},{"id":"250","span":{"begin":175,"end":188},"obj":"Gene"},{"id":"251","span":{"begin":207,"end":210},"obj":"Gene"},{"id":"252","span":{"begin":211,"end":215},"obj":"Gene"},{"id":"273","span":{"begin":248,"end":256},"obj":"Species"},{"id":"274","span":{"begin":257,"end":265},"obj":"Species"},{"id":"297","span":{"begin":91,"end":119},"obj":"Disease"},{"id":"298","span":{"begin":130,"end":141},"obj":"Disease"},{"id":"299","span":{"begin":221,"end":232},"obj":"Disease"}],"attributes":[{"id":"A249","pred":"tao:has_database_id","subj":"249","obj":"Gene:5972"},{"id":"A250","pred":"tao:has_database_id","subj":"250","obj":"Gene:183"},{"id":"A251","pred":"tao:has_database_id","subj":"251","obj":"Gene:59272"},{"id":"A252","pred":"tao:has_database_id","subj":"252","obj":"Gene:59272"},{"id":"A273","pred":"tao:has_database_id","subj":"273","obj":"Tax:694009"},{"id":"A274","pred":"tao:has_database_id","subj":"274","obj":"Tax:9606"},{"id":"A297","pred":"tao:has_database_id","subj":"297","obj":"MESH:D002318"},{"id":"A298","pred":"tao:has_database_id","subj":"298","obj":"MESH:D007022"},{"id":"A299","pred":"tao:has_database_id","subj":"299","obj":"MESH:D013610"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"To this regard, sACE2 was also associated with myocardial pathological conditions [22] and cardiovascular complications including hypotension (known to enhance both renin and angiotensin I, the substrate of ACE/ACE2) and tachycardia were common in SARS-CoV patients [23]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T72","span":{"begin":130,"end":141},"obj":"Disease"},{"id":"T73","span":{"begin":248,"end":256},"obj":"Disease"},{"id":"T74","span":{"begin":248,"end":252},"obj":"Disease"}],"attributes":[{"id":"A72","pred":"mondo_id","subj":"T72","obj":"http://purl.obolibrary.org/obo/MONDO_0005468"},{"id":"A73","pred":"mondo_id","subj":"T73","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A74","pred":"mondo_id","subj":"T74","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"To this regard, sACE2 was also associated with myocardial pathological conditions [22] and cardiovascular complications including hypotension (known to enhance both renin and angiotensin I, the substrate of ACE/ACE2) and tachycardia were common in SARS-CoV patients [23]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T83841","span":{"begin":83,"end":85},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"}],"text":"To this regard, sACE2 was also associated with myocardial pathological conditions [22] and cardiovascular complications including hypotension (known to enhance both renin and angiotensin I, the substrate of ACE/ACE2) and tachycardia were common in SARS-CoV patients [23]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T41","span":{"begin":175,"end":186},"obj":"Chemical"}],"attributes":[{"id":"A41","pred":"chebi_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"}],"text":"To this regard, sACE2 was also associated with myocardial pathological conditions [22] and cardiovascular complications including hypotension (known to enhance both renin and angiotensin I, the substrate of ACE/ACE2) and tachycardia were common in SARS-CoV patients [23]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T33","span":{"begin":0,"end":271},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To this regard, sACE2 was also associated with myocardial pathological conditions [22] and cardiovascular complications including hypotension (known to enhance both renin and angiotensin I, the substrate of ACE/ACE2) and tachycardia were common in SARS-CoV patients [23]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T14","span":{"begin":130,"end":141},"obj":"Phenotype"},{"id":"T15","span":{"begin":221,"end":232},"obj":"Phenotype"}],"attributes":[{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0002615"},{"id":"A15","pred":"hp_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/HP_0001649"}],"text":"To this regard, sACE2 was also associated with myocardial pathological conditions [22] and cardiovascular complications including hypotension (known to enhance both renin and angiotensin I, the substrate of ACE/ACE2) and tachycardia were common in SARS-CoV patients [23]."}

{"project":"2_test","denotations":[{"id":"32708755-19700132-20678671","span":{"begin":83,"end":85},"obj":"19700132"},{"id":"32708755-16461478-20678672","span":{"begin":267,"end":269},"obj":"16461478"}],"text":"To this regard, sACE2 was also associated with myocardial pathological conditions [22] and cardiovascular complications including hypotension (known to enhance both renin and angiotensin I, the substrate of ACE/ACE2) and tachycardia were common in SARS-CoV patients [23]."}